Spineart received approval from the U.S. Food and Drug Administration for the SCARLET AC-T cervical secured cage system.
The system is designed to combine the benefits of an interbody device and cervical plate in one implant. It aims to reducie the profile and potential risks associated with dysphagia.
Spineart is a privately held medical device company focused on developing technologies in the fields of minimally invasive surgery, motion preservation, fusion, biologics and fractures treatment.
More articles on devices:
37 spine, orthopedic devices receive FDA 510(k) clearance in September
Nevro files IPO — 6 things to know
BD buys CareFusion for $12.2B: 8 things to know